ADX10059 + ADX10059 + ADX10059 + ADX10059 Matching Placebo

Phase 2Completed
0 watching 0 views this week Active
44
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Gastroesophageal Reflux

Conditions

Gastroesophageal Reflux

Trial Timeline

Dec 1, 2008 → —

About ADX10059 + ADX10059 + ADX10059 + ADX10059 Matching Placebo

ADX10059 + ADX10059 + ADX10059 + ADX10059 Matching Placebo is a phase 2 stage product being developed by Addex Therapeutics for Gastroesophageal Reflux. The current trial status is completed. This product is registered under clinical trial identifier NCT00810485. Target conditions include Gastroesophageal Reflux.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00810485Phase 2Completed
NCT00820105Phase 2Terminated